DWA
BSX icon

Dorsey Wright & Associates’s Boston Scientific BSX Stock Holding History

Dorsey Wright & Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,232
Closed -$1.64M – 142
2025
Q2 		$1.64M Buy
+15,232
New +$1.54M 0.39% 85
2014
Q3 		– Sell
-100,233
Closed -$1.31M – 130
2014
Q2 		$1.31M Sell
100,233
-3,797
-4% -$49.4K 0.15% 59
2014
Q1 		$1.39M Buy
104,030
+4,921
+5% +$64.6K 0.19% 53
2013
Q4 		$1.31M Buy
99,109
+1,352
+1% +$16K 0.19% 52
2013
Q3 		$1.15M Buy
+97,757
New +$1.06M 0.16% 53

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dorsey Wright & Associates's BSX Position: Q3 2025 in Review

Dorsey Wright & Associates sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 15,232 shares — an estimated $1.64M sold.

Dorsey Wright & Associates first reported a position in BSX in Q3 2013 and held it in 5 quarters. The position peaked at $1.64M in Q2 2025. 1,715 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Dorsey Wright & Associates reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Dorsey Wright & Associates sold 15,232 Boston Scientific shares in Q3 2025, an estimated $1.64M.
  • Dorsey Wright & Associates first reported a position in Boston Scientific in Q3 2013 and held it in 5 quarters.
  • Dorsey Wright & Associates's Boston Scientific position peaked at $1.64M in Q2 2025.
  • 1,715 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Dorsey Wright & Associates's 13F filing for Q3 2025, filed 18 Nov 2025.